Literature DB >> 16395524

Transforming growth factor-beta1 induces transdifferentiation of fibroblasts into myofibroblasts in hypoxic pulmonary vascular remodeling.

Yong-Liang Jiang1, Ai-Guo Dai, Qi-Fang Li, Rui-Cheng Hu.   

Abstract

The muscularization of non-muscular pulmonary arterioles is an important pathological feature of hypoxic pulmonary vascular remodeling. However, the origin of the cells involved in this process is still not well understood. The present study was undertaken to test the hypothesis that transforming growth factor-beta1 (TGF-beta1) can induce transdifferentiation of fibroblasts into myofibroblasts, which might play a key role in the muscularization of non-muscular pulmonary arterioles. It was found that mean pulmonary arterial pressure increased significantly after 7 d of hypoxia. Pulmonary artery remodeling index and right ventricular hypertrophy became evident after 14 d of hypoxia. The distribution of nonmuscular, partially muscular, and muscular vessels was significantly different after 7 d of hypoxia. Immunocytochemistry results demonstrated that the expression of a-smooth muscle actin was increased in intra-acinar pulmonary arteries with increasing hypoxic time. TGF-beta1 mRNA expression in pulmonary arterial walls was increased significantly after 14 d of hypoxia, but showed no obvious changes after 3 or 7 d of hypoxia. In pulmonary tunica adventitia and tunica media, TGF-beta1 protein staining was poorly positive in control rats, but was markedly enhanced after 3 d of hypoxia, reaching its peak after 7 d of hypoxia. The myofibroblast phenotype was confirmed by electron microscopy, which revealed microfilaments and a well-developed rough endoplasmic reticulum. Taken together, our results suggested that TGF-beta1 induces transdifferentiation of fibroblasts into myofibroblasts, which is important in hypoxic pulmonary vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395524     DOI: 10.1111/j.1745-7270.2006.00123.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  10 in total

Review 1.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

2.  Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial.

Authors:  Xiao-Ke Shang; Rong Lu; Xi Zhang; Chang-Dong Zhang; Shu-Na Xiao; Mei Liu; Bin Wang; Nian-Guo Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

3.  Tissue reaction to urogynecologic meshes: effect of steroid soaking in two different mesh models.

Authors:  Aysun Karabulut; Serap Aynur Simavlı; Gülçin Mete Abban; Şahika Pınar Akyer; Nazan Keskin; Semih Tan; Barbaros Şahin
Journal:  Int Urogynecol J       Date:  2016-04-02       Impact factor: 2.894

4.  Sulfur Dioxide Protects Against Collagen Accumulation in Pulmonary Artery in Association With Downregulation of the Transforming Growth Factor β1/Smad Pathway in Pulmonary Hypertensive Rats.

Authors:  Wen Yu; Die Liu; Chen Liang; Todd Ochs; Stella Chen; Selena Chen; Shuxu Du; Chaoshu Tang; Yaqian Huang; Junbao Du; Hongfang Jin
Journal:  J Am Heart Assoc       Date:  2016-10-17       Impact factor: 5.501

5.  Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1.

Authors:  Peijin Shang; Tianlong Liu; Wenxing Liu; Yuwen Li; Fang Dou; Yikai Zhang; Lijuan Sun; Tiejun Zhang; Zhihui Zhu; Fei Mu; Yi Ding; Aidong Wen
Journal:  Mol Med Rep       Date:  2017-08-04       Impact factor: 2.952

6.  Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway.

Authors:  Qian Lei; Zhimin Yu; Hang Li; Jun Cheng; Yanggan Wang
Journal:  J Adv Res       Date:  2021-11-26       Impact factor: 12.822

7.  Experimental Studies on the Differentiation of Fibroblasts into Myoblasts induced by MyoD Genes in vitro.

Authors:  Zhongmin Liu; Huimin Fan; Yang Li; Song Guo Zheng
Journal:  Int J Biomed Sci       Date:  2008-03

8.  Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling.

Authors:  Jiro Ikeda; Toshihiro Ichiki; Hirohide Matsuura; Eriko Inoue; Junji Kishimoto; Aya Watanabe; Chikahiro Sankoda; Shiro Kitamoto; Tomotake Tokunou; Kotaro Takeda; Guo-Hua Fong; Kenji Sunagawa
Journal:  J Am Heart Assoc       Date:  2013-06-18       Impact factor: 5.501

9.  Ezrin Regulating the Cytoskeleton Remodeling is Required for Hypoxia-Induced Myofibroblast Proliferation and Migration.

Authors:  Bin Yi; Lin Chen; Jing Zeng; Jian Cui; Guansong Wang; Guisheng Qian; Karine Belguise; Xiaobo Wang; Kaizhi Lu
Journal:  Front Cardiovasc Med       Date:  2015-03-03

Review 10.  MicroRNAs in pulmonary arterial remodeling.

Authors:  Jennifer S Grant; Kevin White; Margaret R MacLean; Andrew H Baker
Journal:  Cell Mol Life Sci       Date:  2013-06-06       Impact factor: 9.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.